Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Chip McVickar who wrote (711)	3/20/2000 3:03:00 PM
From: OldAIMGuy	Respond to of 1154

Hi Chip and All, I took a week of "Spring Break" and just got back. Looks like nobody was minding the store while I was gone! Who let the Arkansas Lecher in on the BioTech revolution? What's BioTech Bill know anyway? Well, the highest price I got for GENE shares that I sold was $63.75. At that point the account was 50% Cash Reserve and my indicated first buy-back was about $24. I really didn't think it would happen so quickly, but the price is nearly there now! With GENE down to about $25, I may want to let some dust settle before I do any buying. I'll keep you all posted when I do start buying shares back again. It may be a bit early. In the mean time the Cash Reserve is now earning me about 5% - significantly higher than the GENE shares were paying in dividends! :-) My NERX and BPUR both gave back some of their premium as well. Both are holding up better than what GENE is currently showing. Best regards, Tom